Loading...
Keywords
Last Name
Institution
 Back to Profile

Jennifer Schuster

Concepts (367)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiratory Tract Infections
17
2024
82
5.060
 Why?
Influenza, Human
17
2024
62
4.670
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
50
4.170
 Why?
Influenza Vaccines
12
2024
26
3.820
 Why?
Humans
115
2024
6929
3.820
 Why?
Child
81
2024
3348
3.450
 Why?
Enterovirus Infections
12
2023
37
3.350
 Why?
Enterovirus D, Human
11
2023
25
3.130
 Why?
Schools
10
2024
56
2.970
 Why?
Hospitalization
34
2024
209
2.710
 Why?
Child, Preschool
41
2024
1562
2.620
 Why?
United States
38
2024
670
2.410
 Why?
Influenza A Virus, H1N1 Subtype
7
2024
13
2.220
 Why?
Metapneumovirus
9
2022
12
2.210
 Why?
Paramyxoviridae Infections
8
2016
12
2.130
 Why?
Adolescent
46
2024
2183
2.080
 Why?
Antibodies, Viral
9
2024
47
1.970
 Why?
Disease Outbreaks
11
2023
29
1.790
 Why?
Infant
35
2024
1449
1.680
 Why?
Female
40
2024
3534
1.650
 Why?
Virus Diseases
3
2024
16
1.580
 Why?
Male
39
2024
3367
1.560
 Why?
Rhinovirus
5
2023
11
1.540
 Why?
Systemic Inflammatory Response Syndrome
11
2024
17
1.480
 Why?
Respiratory Syncytial Virus Infections
8
2024
50
1.460
 Why?
Prospective Studies
21
2024
547
1.420
 Why?
Vaccination
16
2024
70
1.310
 Why?
Mucocutaneous Lymph Node Syndrome
5
2021
9
1.230
 Why?
Students
3
2024
34
1.170
 Why?
Pandemics
11
2024
81
1.130
 Why?
Vulnerable Populations
2
2023
7
1.050
 Why?
Respiratory Syncytial Virus, Human
4
2024
27
0.940
 Why?
Gastroenteritis
2
2022
26
0.930
 Why?
Antibodies, Neutralizing
5
2021
31
0.850
 Why?
Viruses
2
2022
5
0.850
 Why?
Pneumonia, Viral
3
2020
16
0.820
 Why?
Communicable Diseases
2
2022
8
0.820
 Why?
Case-Control Studies
14
2024
216
0.820
 Why?
Touch
1
2021
1
0.820
 Why?
Vaccines
2
2023
17
0.820
 Why?
School Health Services
1
2022
9
0.820
 Why?
Spike Glycoprotein, Coronavirus
2
2022
19
0.820
 Why?
Respiratory System
1
2021
5
0.810
 Why?
Immunization Schedule
2
2017
10
0.740
 Why?
Asymptomatic Infections
1
2020
3
0.730
 Why?
Antibodies, Monoclonal, Humanized
2
2024
33
0.710
 Why?
Influenza A Virus, H3N2 Subtype
7
2024
12
0.700
 Why?
Adult
12
2024
1199
0.680
 Why?
Seasons
11
2024
35
0.680
 Why?
Asthma
5
2023
152
0.680
 Why?
Immunoglobulins, Intravenous
5
2023
10
0.670
 Why?
Hematologic Diseases
1
2018
4
0.660
 Why?
Immunologic Deficiency Syndromes
1
2018
8
0.660
 Why?
Critical Care
4
2021
12
0.650
 Why?
Communicable Diseases, Emerging
1
2018
3
0.630
 Why?
Picornaviridae Infections
1
2018
21
0.630
 Why?
Communicable Disease Control
1
2018
5
0.630
 Why?
Hyponatremia
1
2017
2
0.620
 Why?
Retrospective Studies
11
2023
1337
0.590
 Why?
Hospitals, Pediatric
8
2024
186
0.580
 Why?
Public Health Practice
1
2016
1
0.570
 Why?
Immunization Programs
1
2016
6
0.570
 Why?
Infectious Disease Medicine
2
2022
4
0.560
 Why?
Neoplasms
1
2018
126
0.550
 Why?
Coronavirus Infections
3
2020
15
0.520
 Why?
Specialization
1
2014
7
0.500
 Why?
Missouri
3
2024
77
0.490
 Why?
Treatment Outcome
6
2021
649
0.470
 Why?
Meningitis, Fungal
1
2013
1
0.460
 Why?
Histoplasma
1
2013
3
0.460
 Why?
Histoplasmosis
1
2013
3
0.460
 Why?
Connective Tissue Diseases
2
2023
5
0.450
 Why?
Immunocompromised Host
2
2024
10
0.430
 Why?
Pediatrics
1
2014
183
0.420
 Why?
Nervous System Diseases
2
2023
13
0.410
 Why?
Prevalence
3
2023
150
0.410
 Why?
Infant, Newborn
9
2024
826
0.410
 Why?
Fever
4
2021
27
0.400
 Why?
Population Surveillance
2
2021
13
0.400
 Why?
Myelitis
2
2022
5
0.400
 Why?
Respiratory Syncytial Virus Vaccines
2
2024
8
0.390
 Why?
Risk Factors
4
2023
490
0.390
 Why?
Longitudinal Studies
3
2020
119
0.380
 Why?
Intensive Care Units
4
2023
18
0.380
 Why?
Infliximab
2
2021
7
0.370
 Why?
Vaccines, Synthetic
4
2022
9
0.360
 Why?
Interferon Type I
2
2022
5
0.350
 Why?
Critical Illness
3
2022
22
0.320
 Why?
Autoantibodies
2
2024
10
0.300
 Why?
Severity of Illness Index
2
2020
148
0.300
 Why?
Transplant Recipients
2
2024
9
0.300
 Why?
Glucocorticoids
3
2023
31
0.290
 Why?
Intensive Care Units, Pediatric
2
2024
11
0.290
 Why?
Respiratory Syncytial Viruses
2
2024
18
0.290
 Why?
Animals
6
2016
741
0.290
 Why?
Advisory Committees
2
2017
9
0.290
 Why?
Cross-Over Studies
3
2023
35
0.290
 Why?
International Classification of Diseases
2
2024
11
0.280
 Why?
Length of Stay
4
2020
243
0.270
 Why?
Pregnancy Complications, Infectious
2
2022
18
0.260
 Why?
Minority Groups
2
2022
16
0.260
 Why?
Cross-Sectional Studies
4
2023
333
0.260
 Why?
Pregnancy
5
2024
212
0.250
 Why?
Molecular Mimicry
1
2024
3
0.250
 Why?
Cross Reactions
1
2024
8
0.250
 Why?
Epitopes
1
2024
20
0.250
 Why?
Adenoviruses, Human
1
2024
2
0.240
 Why?
Adenovirus Infections, Human
1
2024
4
0.240
 Why?
Disease Models, Animal
2
2014
61
0.240
 Why?
Public Health Surveillance
2
2021
4
0.240
 Why?
School Nursing
1
2024
5
0.240
 Why?
Nurse's Role
1
2024
10
0.240
 Why?
Hemagglutination Inhibition Tests
1
2024
1
0.240
 Why?
Vaccines, Inactivated
1
2024
2
0.240
 Why?
Antibody Formation
1
2024
4
0.240
 Why?
Acute Disease
2
2022
77
0.240
 Why?
Pneumonia, Mycoplasma
1
2024
15
0.240
 Why?
Health Knowledge, Attitudes, Practice
1
2024
63
0.230
 Why?
Central Nervous System Viral Diseases
2
2022
6
0.230
 Why?
Neuromuscular Diseases
2
2022
7
0.230
 Why?
Echocardiography
3
2020
93
0.230
 Why?
Common Data Elements
1
2023
2
0.230
 Why?
Acceleration
1
2023
4
0.230
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2023
2
0.230
 Why?
Immunoglobulin G
2
2021
34
0.230
 Why?
Respiratory Insufficiency
1
2023
13
0.220
 Why?
Disease Progression
3
2023
110
0.220
 Why?
Educational Status
1
2023
21
0.220
 Why?
Guillain-Barre Syndrome
1
2023
1
0.220
 Why?
Extracorporeal Membrane Oxygenation
1
2023
17
0.220
 Why?
Stroke
1
2023
22
0.220
 Why?
CD8-Positive T-Lymphocytes
3
2022
14
0.220
 Why?
RNA, Messenger
4
2024
115
0.220
 Why?
Enterovirus
1
2023
12
0.220
 Why?
Age Factors
3
2021
211
0.210
 Why?
Regression Analysis
2
2021
52
0.210
 Why?
Coinfection
1
2022
5
0.210
 Why?
Neutralization Tests
3
2022
6
0.210
 Why?
Rotavirus
1
2022
11
0.210
 Why?
Immunity, Maternally-Acquired
1
2022
1
0.210
 Why?
Rotavirus Infections
1
2022
15
0.210
 Why?
Rotavirus Vaccines
1
2022
13
0.210
 Why?
Community-Institutional Relations
1
2022
5
0.210
 Why?
Academic Medical Centers
1
2022
10
0.210
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2020
72
0.210
 Why?
Child, Hospitalized
1
2022
26
0.210
 Why?
Cohort Studies
4
2024
281
0.210
 Why?
Disabled Children
1
2022
8
0.210
 Why?
Education, Distance
1
2022
6
0.200
 Why?
Urban Population
1
2022
27
0.200
 Why?
Herpesvirus 1, Cercopithecine
1
2021
2
0.200
 Why?
Young Adult
5
2022
641
0.200
 Why?
Molecular Diagnostic Techniques
2
2021
38
0.200
 Why?
Emergency Service, Hospital
4
2024
129
0.200
 Why?
Follow-Up Studies
2
2021
329
0.200
 Why?
Vaccine Potency
1
2021
7
0.200
 Why?
Ventricular Dysfunction, Left
1
2021
18
0.190
 Why?
Tomography, X-Ray Computed
2
2021
130
0.190
 Why?
Respiration, Artificial
4
2023
16
0.190
 Why?
Mouth
1
2020
3
0.180
 Why?
DNA, Viral
1
2020
13
0.180
 Why?
Monitoring, Physiologic
1
2020
23
0.180
 Why?
Postoperative Care
1
2020
29
0.180
 Why?
Risk Assessment
1
2020
136
0.170
 Why?
Prognosis
1
2020
216
0.170
 Why?
Biomarkers
2
2021
132
0.170
 Why?
Cough
2
2015
7
0.170
 Why?
Mothers
3
2024
33
0.170
 Why?
Diagnosis, Differential
2
2021
78
0.160
 Why?
Metabolic Diseases
1
2018
12
0.160
 Why?
Virus Replication
2
2015
6
0.160
 Why?
Recurrence
2
2021
121
0.160
 Why?
Reassortant Viruses
1
2018
1
0.160
 Why?
Orthomyxoviridae
1
2018
2
0.160
 Why?
Organoplatinum Compounds
1
2017
1
0.160
 Why?
Sodium
1
2017
7
0.150
 Why?
Hypotension
1
2017
4
0.150
 Why?
Influenza B virus
3
2022
22
0.150
 Why?
Magnetic Resonance Imaging
3
2020
122
0.150
 Why?
Patient Acuity
3
2022
7
0.150
 Why?
Yellow Fever Vaccine
1
2017
1
0.150
 Why?
Meningococcal Vaccines
1
2017
2
0.150
 Why?
Herpes Zoster Vaccine
1
2017
2
0.150
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2017
3
0.150
 Why?
Pneumococcal Vaccines
1
2017
4
0.150
 Why?
Hepatitis B Vaccines
1
2017
2
0.150
 Why?
Patient Discharge
3
2022
61
0.150
 Why?
Papillomavirus Vaccines
1
2017
6
0.150
 Why?
Practice Guidelines as Topic
1
2017
104
0.140
 Why?
Mutation
1
2018
213
0.140
 Why?
Societies, Medical
1
2016
50
0.140
 Why?
Replicon
1
2016
1
0.140
 Why?
Virus Internalization
1
2015
1
0.140
 Why?
Recombination, Genetic
1
2015
5
0.140
 Why?
Jordan
1
2015
1
0.140
 Why?
Respiratory Mucosa
1
2015
4
0.140
 Why?
Viral Vaccines
1
2016
10
0.130
 Why?
Tertiary Care Centers
1
2015
10
0.130
 Why?
Vaccines, Virus-Like Particle
1
2015
1
0.130
 Why?
Disease Management
1
2015
36
0.130
 Why?
Community Networks
1
2014
2
0.130
 Why?
Cross Protection
1
2014
1
0.120
 Why?
Seroepidemiologic Studies
1
2014
3
0.120
 Why?
Lung
1
2015
66
0.120
 Why?
Disease Transmission, Infectious
1
2014
4
0.120
 Why?
Emergency Medical Services
1
2014
15
0.120
 Why?
Antibodies, Monoclonal
1
2014
23
0.120
 Why?
Mice, Inbred DBA
1
2014
3
0.120
 Why?
Chemoprevention
1
2014
4
0.120
 Why?
Mice, Inbred BALB C
1
2014
25
0.120
 Why?
Physicians
1
2014
24
0.120
 Why?
Genetic Variation
1
2015
166
0.120
 Why?
Immunotherapy
1
2014
16
0.120
 Why?
Gene Expression Regulation
1
2015
103
0.120
 Why?
Signal Transduction
1
2015
133
0.120
 Why?
Cytopathogenic Effect, Viral
1
2013
2
0.120
 Why?
Virulence
1
2013
7
0.120
 Why?
Opportunistic Infections
1
2013
7
0.120
 Why?
Bronchiolitis
1
2013
10
0.120
 Why?
Leukocytes, Mononuclear
2
2024
15
0.110
 Why?
Predictive Value of Tests
1
2013
102
0.110
 Why?
Polymerase Chain Reaction
1
2013
85
0.110
 Why?
Radiography
1
2013
49
0.110
 Why?
Chronic Disease
1
2013
106
0.110
 Why?
Aftercare
2
2022
5
0.110
 Why?
Brain
1
2013
79
0.110
 Why?
Stroke Volume
2
2023
20
0.100
 Why?
Prisoners
1
2011
1
0.100
 Why?
Vietnam Conflict
1
2011
1
0.100
 Why?
Veterans
1
2011
2
0.100
 Why?
Viral Fusion Proteins
3
2016
4
0.100
 Why?
Obesity
2
2023
124
0.100
 Why?
Adaptation, Psychological
1
2011
38
0.100
 Why?
Stress, Psychological
1
2011
32
0.100
 Why?
Inflammation
2
2023
49
0.100
 Why?
Immunomodulation
2
2021
2
0.100
 Why?
Sulfonylurea Compounds
1
2007
1
0.070
 Why?
Thiazolidinediones
1
2007
1
0.070
 Why?
Hypoglycemic Agents
1
2007
34
0.070
 Why?
Mice
3
2015
339
0.070
 Why?
Drug Therapy, Combination
2
2021
37
0.070
 Why?
Flow Cytometry
2
2015
32
0.070
 Why?
Mice, Inbred C57BL
2
2015
90
0.060
 Why?
Sorting Nexins
1
2024
1
0.060
 Why?
Phosphoproteins
1
2024
15
0.060
 Why?
Hospital Mortality
1
2024
24
0.060
 Why?
T-Lymphocytes
1
2024
31
0.060
 Why?
Transplantation, Homologous
1
2024
21
0.060
 Why?
Focus Groups
1
2024
12
0.060
 Why?
Antibodies, Bacterial
1
2024
8
0.060
 Why?
RNA, Messenger, Stored
1
2023
1
0.060
 Why?
Sensitivity and Specificity
1
2024
151
0.060
 Why?
Reproducibility of Results
1
2024
198
0.060
 Why?
C-Reactive Protein
1
2023
16
0.060
 Why?
Crowding
1
2023
4
0.060
 Why?
Kansas
1
2023
43
0.060
 Why?
Family Characteristics
1
2023
9
0.060
 Why?
Ventricular Function, Left
1
2023
30
0.060
 Why?
Sialic Acid Binding Ig-like Lectin 2
1
2023
1
0.060
 Why?
Receptor, Notch1
1
2023
2
0.060
 Why?
Research Design
1
2023
63
0.060
 Why?
T-Lymphocytes, Regulatory
1
2023
7
0.060
 Why?
NF-kappa B p52 Subunit
1
2022
1
0.060
 Why?
Haploinsufficiency
1
2022
11
0.050
 Why?
NF-kappa B
1
2022
14
0.050
 Why?
Immunity, Cellular
1
2022
18
0.050
 Why?
Adenoviridae
1
2022
6
0.050
 Why?
Oxygen
1
2022
13
0.050
 Why?
Immunity, Humoral
1
2022
14
0.050
 Why?
Antigens, Viral
1
2022
7
0.050
 Why?
Immunoassay
1
2022
10
0.050
 Why?
Policy
1
2022
3
0.050
 Why?
Viral Envelope Proteins
1
2022
3
0.050
 Why?
Vaccines, Attenuated
1
2022
8
0.050
 Why?
Inpatients
1
2023
43
0.050
 Why?
Membrane Glycoproteins
1
2022
14
0.050
 Why?
Immunization, Passive
1
2022
1
0.050
 Why?
Infectious Disease Transmission, Vertical
1
2022
8
0.050
 Why?
Pilot Projects
1
2022
114
0.050
 Why?
Electronic Health Records
1
2023
65
0.050
 Why?
Life Support Care
1
2022
1
0.050
 Why?
Immunization, Secondary
1
2022
2
0.050
 Why?
Saliva
1
2021
10
0.050
 Why?
Surveys and Questionnaires
1
2023
275
0.050
 Why?
Specimen Handling
1
2021
17
0.050
 Why?
Nasopharynx
1
2021
25
0.050
 Why?
Propensity Score
1
2021
8
0.050
 Why?
Shock
1
2021
6
0.050
 Why?
Combined Modality Therapy
1
2021
47
0.050
 Why?
Logistic Models
1
2021
85
0.050
 Why?
Comorbidity
1
2021
56
0.050
 Why?
Clinical Laboratory Techniques
1
2020
9
0.050
 Why?
Hospital Costs
1
2020
31
0.050
 Why?
Middle Aged
2
2015
645
0.040
 Why?
Time Factors
1
2020
263
0.040
 Why?
Cancer Vaccines
1
1999
2
0.040
 Why?
Lymph Nodes
1
1999
3
0.040
 Why?
Lymphatic Metastasis
1
1999
4
0.040
 Why?
Drug Resistance
1
2019
7
0.040
 Why?
Inflammation Mediators
1
2019
8
0.040
 Why?
Comparative Effectiveness Research
1
2019
6
0.040
 Why?
Kidney Neoplasms
1
1999
11
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2019
12
0.040
 Why?
Multicenter Studies as Topic
1
2019
19
0.040
 Why?
Melanoma
1
1999
12
0.040
 Why?
Breast Neoplasms
1
1999
39
0.040
 Why?
Randomized Controlled Trials as Topic
1
2019
57
0.040
 Why?
Materials Testing
1
1998
1
0.040
 Why?
Aerosols
1
1998
4
0.040
 Why?
Nebulizers and Vaporizers
1
1998
8
0.040
 Why?
Drug Delivery Systems
1
1998
6
0.040
 Why?
Practice Patterns, Nurses'
1
2017
5
0.040
 Why?
Aged
2
2015
411
0.040
 Why?
Algorithms
1
2017
108
0.040
 Why?
Practice Patterns, Physicians'
1
2017
85
0.040
 Why?
Alphavirus
1
2016
1
0.030
 Why?
Encephalitis Virus, Venezuelan Equine
1
2016
1
0.030
 Why?
Bronchoalveolar Lavage Fluid
1
2016
12
0.030
 Why?
Nose
1
2016
5
0.030
 Why?
Sequence Homology
1
2015
2
0.030
 Why?
Bronchi
1
2015
1
0.030
 Why?
Endosomes
1
2015
1
0.030
 Why?
Genome, Viral
1
2015
4
0.030
 Why?
Evolution, Molecular
1
2015
5
0.030
 Why?
Molecular Epidemiology
1
2015
6
0.030
 Why?
Transfection
1
2015
23
0.030
 Why?
Microscopy, Confocal
1
2015
19
0.030
 Why?
Phylogeny
1
2015
23
0.030
 Why?
RNA, Small Interfering
1
2015
22
0.030
 Why?
Dyspnea
1
2015
4
0.030
 Why?
Illinois
1
2015
5
0.030
 Why?
Colorado
1
2015
9
0.030
 Why?
Respiratory Sounds
1
2015
6
0.030
 Why?
Molecular Sequence Data
1
2015
78
0.030
 Why?
Cluster Analysis
1
2015
43
0.030
 Why?
Cell Line
1
2015
79
0.030
 Why?
Lymphocyte Depletion
1
2015
1
0.030
 Why?
Programmed Cell Death 1 Receptor
1
2015
4
0.030
 Why?
Viral Matrix Proteins
1
2015
2
0.030
 Why?
HEK293 Cells
1
2015
32
0.030
 Why?
Macaca mulatta
1
2015
22
0.030
 Why?
Mice, Transgenic
1
2015
35
0.030
 Why?
Aged, 80 and over
1
2015
168
0.030
 Why?
Sequence Analysis, DNA
1
2015
116
0.030
 Why?
Receptors, Virus
1
2015
2
0.030
 Why?
Antigen-Presenting Cells
1
2015
2
0.030
 Why?
Analysis of Variance
1
2015
25
0.030
 Why?
Oximetry
1
2015
9
0.030
 Why?
Mice, Knockout
1
2015
60
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2015
100
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
41
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2011
4
0.030
 Why?
Interviews as Topic
1
2011
20
0.030
 Why?
Cerebral Infarction
1
1990
1
0.020
 Why?
Hand
1
1990
3
0.020
 Why?
Movement
1
1990
8
0.020
 Why?
Therapeutic Equivalency
1
2007
5
0.020
 Why?
Biological Availability
1
2007
8
0.020
 Why?
Drug Combinations
1
2007
20
0.020
 Why?
Area Under Curve
1
2007
34
0.020
 Why?
Sex Factors
1
2007
68
0.020
 Why?
Equipment Design
1
1998
14
0.010
 Why?
Administration, Inhalation
1
1998
19
0.010
 Why?
Frontal Lobe
1
1990
1
0.010
 Why?
Corpus Callosum
1
1990
5
0.010
 Why?
Accidents, Traffic
1
1990
18
0.010
 Why?
Craniocerebral Trauma
1
1990
19
0.010
 Why?
Schuster's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (367) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_